1-[2-[3-[9-(4-tert-butyl-2-pyridinyl)xanthen-9-yl]phenoxy]-4-pyridinyl]-3-methyl-2H-benzimidazole
C41H36N4O2 — CID 168848606
Data last refreshed: (MolForge compound catalog, from PubChem)
About 1-[2-[3-[9-(4-tert-butyl-2-pyridinyl)xanthen-9-yl]phenoxy]-4-pyridinyl]-3-methyl-2H-benzimidazole
1-[2-[3-[9-(4-tert-butyl-2-pyridinyl)xanthen-9-yl]phenoxy]-4-pyridinyl]-3-methyl-2H-benzimidazole (PubChem CID 168848606) has the molecular formula C41H36N4O2 and a molecular weight of 616.77 g/mol. Its IUPAC name is 1-[2-[3-[9-(4-tert-butyl-2-pyridinyl)xanthen-9-yl]phenoxy]-4-pyridinyl]-3-methyl-2H-benzimidazole.
Molecular Properties
| Compound Name | 1-[2-[3-[9-(4-tert-butyl-2-pyridinyl)xanthen-9-yl]phenoxy]-4-pyridinyl]-3-methyl-2H-benzimidazole |
|---|---|
| PubChem CID | 168848606 |
| Molecular Formula | C41H36N4O2 |
| Molecular Weight | 616.77 g/mol |
| Exact Mass | 616.28 |
| IUPAC Name | 1-[2-[3-[9-(4-tert-butyl-2-pyridinyl)xanthen-9-yl]phenoxy]-4-pyridinyl]-3-methyl-2H-benzimidazole |
| SMILES | CN1CN(c2ccnc(Oc3cccc(C4(c5cc(C(C)(C)C)ccn5)c5ccccc5Oc5ccccc54)c3)c2)c2ccccc21 |
| InChI | InChI=1S/C41H36N4O2/c1-40(2,3)28-20-22-42-38(25-28)41(32-14-5-9-18-36(32)47-37-19-10-6-15-33(37)41)29-12-11-13-31(24-29)46-39-26-30(21-23-43-39)45-27-44(4)34-16-7-8-17-35(34)45/h5-26H,27H2,1-4H3 |
| InChIKey | SIEIZHVOMODJMF-UHFFFAOYSA-N |
| XLogP | 9.60 |
| TPSA | 50.72 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 47 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 616.77 |
| LogP ≤ 5 | 9.60 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 6 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 168848606 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.